---
figid: PMC8350388__fphar-12-690501-g001
figtitle: Role of Traditional Chinese Medicines by Wnt/Beta-Catenin Pathway Compared
  With Targeted Small Molecules in Colorectal Cancer Therapy
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC8350388
filename: fphar-12-690501-g001.jpg
figlink: /pmc/articles/PMC8350388/figure/F1/
number: F1
caption: Schematic illustration of the Wnt/β-catenin signaling pathway in CRC. (A)
  Inactive Wnt/β-catenin pathway. In the absence of Wnt ligands, destruction complex
  phosphylates ß-catenin and KRAS for ubiquitination and proteolytic degradation;
  (B) Active ß-catenin pathway and crosstalk with KRAS/ERK pathway. In the Wnt stimuli
  or APC loss, GSK3β becomes inactive status, leading to the high levels of cytoplasmic
  ß-catenin and KRAS. While KRAS mutations have a positive feedback loop with the
  level of cytoplasmic ß-catenin. In addition, RNF43 mutations can relieve the degradation
  of fizzled protein and activate Wnt/β-catenin pathway.
papertitle: Potential Role of Traditional Chinese Medicines by Wnt/β-Catenin Pathway
  Compared With Targeted Small Molecules in Colorectal Cancer Therapy.
reftext: Jinrong Chang, et al. Front Pharmacol. 2021;12:690501.
year: '2021'
doi: 10.3389/fphar.2021.690501
journal_title: Frontiers in Pharmacology
journal_nlm_ta: Front Pharmacol
publisher_name: Frontiers Media S.A.
keywords: traditional Chinese medicines | colorectal cancer | Wnt/β-catenin | potential
  role | small molecules | therapeutic mechanism
automl_pathway: 0.9347537
figid_alias: PMC8350388__F1
figtype: Figure
redirect_from: /figures/PMC8350388__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8350388__fphar-12-690501-g001.html
  '@type': Dataset
  description: Schematic illustration of the Wnt/β-catenin signaling pathway in CRC.
    (A) Inactive Wnt/β-catenin pathway. In the absence of Wnt ligands, destruction
    complex phosphylates ß-catenin and KRAS for ubiquitination and proteolytic degradation;
    (B) Active ß-catenin pathway and crosstalk with KRAS/ERK pathway. In the Wnt stimuli
    or APC loss, GSK3β becomes inactive status, leading to the high levels of cytoplasmic
    ß-catenin and KRAS. While KRAS mutations have a positive feedback loop with the
    level of cytoplasmic ß-catenin. In addition, RNF43 mutations can relieve the degradation
    of fizzled protein and activate Wnt/β-catenin pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - APC
  - PROC
  - GSK3B
  - CTNNB1
  - BTRC
  - PTPRC
  - HNF4A
  - RPSA
  - LRP1
  - PTPRA
  - MVP
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - KRAS
  - NRAS
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - EP300
  - RNF43
  - EGF
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - EGFR
  - SNAI1
  - MYC
  - LGR5
---
